Polatuzumab vedotin and Tumor lysis syndrome
Result of checking the interaction of drug Polatuzumab vedotin and disease Tumor lysis syndrome for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of polatuzumab vedotin may cause tumor lysis syndrome. Patients with high tumor burden and rapidly proliferative tumor may be at increased risk of tumor lysis syndrome. It is recommended to closely monitor for signs of tumor lysis syndrome and to take appropriate measures, including tumor lysis syndrome prophylaxis as appropriate.
Generic Name: polatuzumab vedotin
Brand Name: Polivy
Synonyms: Polatuzumab Vedotin